nodes	percent_of_prediction	percent_of_DWPC	metapath
Trabectedin—Alkylating Activity—Dacarbazine—pancreatic cancer	0.545	1	CiPCiCtD
Trabectedin—SRC—pancreatic cancer	0.247	1	CbGaD
Trabectedin—CYP2E1—Dacarbazine—pancreatic cancer	0.0226	0.205	CbGbCtD
Trabectedin—CYP2E1—Tamoxifen—pancreatic cancer	0.018	0.163	CbGbCtD
Trabectedin—CYP2C19—Tamoxifen—pancreatic cancer	0.0113	0.102	CbGbCtD
Trabectedin—CYP2C9—Tamoxifen—pancreatic cancer	0.00938	0.085	CbGbCtD
Trabectedin—CYP2D6—Tamoxifen—pancreatic cancer	0.00857	0.0777	CbGbCtD
Trabectedin—CYP2D6—Erlotinib—pancreatic cancer	0.00729	0.0661	CbGbCtD
Trabectedin—CYP2C9—Fluorouracil—pancreatic cancer	0.00691	0.0626	CbGbCtD
Trabectedin—CYP3A4—Tamoxifen—pancreatic cancer	0.00545	0.0494	CbGbCtD
Trabectedin—CYP3A4—Erlotinib—pancreatic cancer	0.00464	0.042	CbGbCtD
Trabectedin—CYP3A4—Irinotecan—pancreatic cancer	0.00419	0.0379	CbGbCtD
Trabectedin—CYP2D6—Doxorubicin—pancreatic cancer	0.0036	0.0326	CbGbCtD
Trabectedin—CYP3A4—Docetaxel—pancreatic cancer	0.00307	0.0278	CbGbCtD
Trabectedin—CYP3A4—Sunitinib—pancreatic cancer	0.00305	0.0277	CbGbCtD
Trabectedin—CYP3A4—Doxorubicin—pancreatic cancer	0.00229	0.0207	CbGbCtD
Trabectedin—Hypotension—Irinotecan—pancreatic cancer	6.89e-05	0.000973	CcSEcCtD
Trabectedin—Anorexia—Gemcitabine—pancreatic cancer	6.84e-05	0.000966	CcSEcCtD
Trabectedin—Dizziness—Erlotinib—pancreatic cancer	6.84e-05	0.000965	CcSEcCtD
Trabectedin—Anorexia—Fluorouracil—pancreatic cancer	6.73e-05	0.00095	CcSEcCtD
Trabectedin—Hypotension—Gemcitabine—pancreatic cancer	6.71e-05	0.000947	CcSEcCtD
Trabectedin—Insomnia—Irinotecan—pancreatic cancer	6.67e-05	0.000941	CcSEcCtD
Trabectedin—Flushing—Docetaxel—pancreatic cancer	6.66e-05	0.00094	CcSEcCtD
Trabectedin—Vomiting—Tamoxifen—pancreatic cancer	6.64e-05	0.000938	CcSEcCtD
Trabectedin—Paraesthesia—Irinotecan—pancreatic cancer	6.62e-05	0.000935	CcSEcCtD
Trabectedin—Hypotension—Fluorouracil—pancreatic cancer	6.6e-05	0.000931	CcSEcCtD
Trabectedin—Hypersensitivity—Sunitinib—pancreatic cancer	6.59e-05	0.000931	CcSEcCtD
Trabectedin—Rash—Tamoxifen—pancreatic cancer	6.59e-05	0.00093	CcSEcCtD
Trabectedin—Dermatitis—Tamoxifen—pancreatic cancer	6.58e-05	0.000929	CcSEcCtD
Trabectedin—Vomiting—Erlotinib—pancreatic cancer	6.57e-05	0.000928	CcSEcCtD
Trabectedin—Dyspnoea—Irinotecan—pancreatic cancer	6.57e-05	0.000928	CcSEcCtD
Trabectedin—Blood creatinine increased—Epirubicin—pancreatic cancer	6.55e-05	0.000925	CcSEcCtD
Trabectedin—Headache—Tamoxifen—pancreatic cancer	6.55e-05	0.000924	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	6.54e-05	0.000924	CcSEcCtD
Trabectedin—Rash—Erlotinib—pancreatic cancer	6.52e-05	0.00092	CcSEcCtD
Trabectedin—Dermatitis—Erlotinib—pancreatic cancer	6.51e-05	0.000919	CcSEcCtD
Trabectedin—Angiopathy—Docetaxel—pancreatic cancer	6.51e-05	0.000919	CcSEcCtD
Trabectedin—Dehydration—Epirubicin—pancreatic cancer	6.5e-05	0.000918	CcSEcCtD
Trabectedin—Insomnia—Gemcitabine—pancreatic cancer	6.49e-05	0.000917	CcSEcCtD
Trabectedin—Dyspepsia—Irinotecan—pancreatic cancer	6.49e-05	0.000916	CcSEcCtD
Trabectedin—Headache—Erlotinib—pancreatic cancer	6.48e-05	0.000914	CcSEcCtD
Trabectedin—Mediastinal disorder—Docetaxel—pancreatic cancer	6.46e-05	0.000913	CcSEcCtD
Trabectedin—Paraesthesia—Gemcitabine—pancreatic cancer	6.45e-05	0.00091	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	6.43e-05	0.000908	CcSEcCtD
Trabectedin—Asthenia—Sunitinib—pancreatic cancer	6.42e-05	0.000907	CcSEcCtD
Trabectedin—Decreased appetite—Irinotecan—pancreatic cancer	6.41e-05	0.000905	CcSEcCtD
Trabectedin—Dyspnoea—Gemcitabine—pancreatic cancer	6.4e-05	0.000904	CcSEcCtD
Trabectedin—Abdominal pain upper—Epirubicin—pancreatic cancer	6.39e-05	0.000902	CcSEcCtD
Trabectedin—Insomnia—Fluorouracil—pancreatic cancer	6.39e-05	0.000902	CcSEcCtD
Trabectedin—Hypokalaemia—Epirubicin—pancreatic cancer	6.36e-05	0.000899	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Irinotecan—pancreatic cancer	6.36e-05	0.000899	CcSEcCtD
Trabectedin—Fatigue—Irinotecan—pancreatic cancer	6.36e-05	0.000897	CcSEcCtD
Trabectedin—Paraesthesia—Fluorouracil—pancreatic cancer	6.34e-05	0.000895	CcSEcCtD
Trabectedin—Alopecia—Docetaxel—pancreatic cancer	6.34e-05	0.000895	CcSEcCtD
Trabectedin—Constipation—Irinotecan—pancreatic cancer	6.3e-05	0.00089	CcSEcCtD
Trabectedin—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	6.3e-05	0.000889	CcSEcCtD
Trabectedin—Dyspnoea—Fluorouracil—pancreatic cancer	6.29e-05	0.000889	CcSEcCtD
Trabectedin—Mental disorder—Docetaxel—pancreatic cancer	6.28e-05	0.000887	CcSEcCtD
Trabectedin—Malnutrition—Docetaxel—pancreatic cancer	6.24e-05	0.000882	CcSEcCtD
Trabectedin—Decreased appetite—Gemcitabine—pancreatic cancer	6.24e-05	0.000881	CcSEcCtD
Trabectedin—Dyspepsia—Fluorouracil—pancreatic cancer	6.21e-05	0.000877	CcSEcCtD
Trabectedin—Nausea—Tamoxifen—pancreatic cancer	6.21e-05	0.000876	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	6.2e-05	0.000875	CcSEcCtD
Trabectedin—Fatigue—Gemcitabine—pancreatic cancer	6.19e-05	0.000874	CcSEcCtD
Trabectedin—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	6.17e-05	0.000871	CcSEcCtD
Trabectedin—Constipation—Gemcitabine—pancreatic cancer	6.14e-05	0.000867	CcSEcCtD
Trabectedin—Nausea—Erlotinib—pancreatic cancer	6.14e-05	0.000867	CcSEcCtD
Trabectedin—Decreased appetite—Fluorouracil—pancreatic cancer	6.14e-05	0.000867	CcSEcCtD
Trabectedin—Diarrhoea—Sunitinib—pancreatic cancer	6.12e-05	0.000865	CcSEcCtD
Trabectedin—Dysgeusia—Docetaxel—pancreatic cancer	6.11e-05	0.000863	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	6.1e-05	0.000861	CcSEcCtD
Trabectedin—Blood creatinine increased—Doxorubicin—pancreatic cancer	6.06e-05	0.000856	CcSEcCtD
Trabectedin—Back pain—Docetaxel—pancreatic cancer	6.04e-05	0.000853	CcSEcCtD
Trabectedin—Gastrointestinal pain—Irinotecan—pancreatic cancer	6.03e-05	0.000851	CcSEcCtD
Trabectedin—Dehydration—Doxorubicin—pancreatic cancer	6.02e-05	0.00085	CcSEcCtD
Trabectedin—Dizziness—Sunitinib—pancreatic cancer	5.92e-05	0.000836	CcSEcCtD
Trabectedin—Abdominal pain upper—Doxorubicin—pancreatic cancer	5.91e-05	0.000834	CcSEcCtD
Trabectedin—Hypokalaemia—Doxorubicin—pancreatic cancer	5.89e-05	0.000831	CcSEcCtD
Trabectedin—Abdominal pain—Irinotecan—pancreatic cancer	5.83e-05	0.000823	CcSEcCtD
Trabectedin—Body temperature increased—Irinotecan—pancreatic cancer	5.83e-05	0.000823	CcSEcCtD
Trabectedin—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	5.83e-05	0.000823	CcSEcCtD
Trabectedin—Anaemia—Docetaxel—pancreatic cancer	5.77e-05	0.000815	CcSEcCtD
Trabectedin—Pancytopenia—Epirubicin—pancreatic cancer	5.74e-05	0.00081	CcSEcCtD
Trabectedin—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	5.71e-05	0.000806	CcSEcCtD
Trabectedin—Vomiting—Sunitinib—pancreatic cancer	5.69e-05	0.000803	CcSEcCtD
Trabectedin—Body temperature increased—Gemcitabine—pancreatic cancer	5.68e-05	0.000801	CcSEcCtD
Trabectedin—Neutropenia—Epirubicin—pancreatic cancer	5.65e-05	0.000798	CcSEcCtD
Trabectedin—Rash—Sunitinib—pancreatic cancer	5.64e-05	0.000797	CcSEcCtD
Trabectedin—Dermatitis—Sunitinib—pancreatic cancer	5.64e-05	0.000796	CcSEcCtD
Trabectedin—Headache—Sunitinib—pancreatic cancer	5.61e-05	0.000792	CcSEcCtD
Trabectedin—Syncope—Docetaxel—pancreatic cancer	5.6e-05	0.000791	CcSEcCtD
Trabectedin—Leukopenia—Docetaxel—pancreatic cancer	5.59e-05	0.000789	CcSEcCtD
Trabectedin—Body temperature increased—Fluorouracil—pancreatic cancer	5.58e-05	0.000788	CcSEcCtD
Trabectedin—Loss of consciousness—Docetaxel—pancreatic cancer	5.49e-05	0.000775	CcSEcCtD
Trabectedin—Weight decreased—Epirubicin—pancreatic cancer	5.47e-05	0.000772	CcSEcCtD
Trabectedin—Cough—Docetaxel—pancreatic cancer	5.45e-05	0.000769	CcSEcCtD
Trabectedin—Hypersensitivity—Irinotecan—pancreatic cancer	5.43e-05	0.000767	CcSEcCtD
Trabectedin—Infestation NOS—Epirubicin—pancreatic cancer	5.39e-05	0.000761	CcSEcCtD
Trabectedin—Infestation—Epirubicin—pancreatic cancer	5.39e-05	0.000761	CcSEcCtD
Trabectedin—Arthralgia—Docetaxel—pancreatic cancer	5.32e-05	0.000751	CcSEcCtD
Trabectedin—Myalgia—Docetaxel—pancreatic cancer	5.32e-05	0.000751	CcSEcCtD
Trabectedin—Nausea—Sunitinib—pancreatic cancer	5.32e-05	0.000751	CcSEcCtD
Trabectedin—Pancytopenia—Doxorubicin—pancreatic cancer	5.31e-05	0.00075	CcSEcCtD
Trabectedin—Asthenia—Irinotecan—pancreatic cancer	5.29e-05	0.000747	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	5.28e-05	0.000745	CcSEcCtD
Trabectedin—Jaundice—Epirubicin—pancreatic cancer	5.25e-05	0.000742	CcSEcCtD
Trabectedin—Stomatitis—Epirubicin—pancreatic cancer	5.25e-05	0.000742	CcSEcCtD
Trabectedin—Neutropenia—Doxorubicin—pancreatic cancer	5.23e-05	0.000738	CcSEcCtD
Trabectedin—Hypersensitivity—Fluorouracil—pancreatic cancer	5.2e-05	0.000734	CcSEcCtD
Trabectedin—Asthenia—Gemcitabine—pancreatic cancer	5.15e-05	0.000727	CcSEcCtD
Trabectedin—Hepatobiliary disease—Epirubicin—pancreatic cancer	5.1e-05	0.00072	CcSEcCtD
Trabectedin—Oedema—Docetaxel—pancreatic cancer	5.1e-05	0.000719	CcSEcCtD
Trabectedin—Infection—Docetaxel—pancreatic cancer	5.06e-05	0.000715	CcSEcCtD
Trabectedin—Weight decreased—Doxorubicin—pancreatic cancer	5.06e-05	0.000714	CcSEcCtD
Trabectedin—Diarrhoea—Irinotecan—pancreatic cancer	5.04e-05	0.000712	CcSEcCtD
Trabectedin—Agranulocytosis—Epirubicin—pancreatic cancer	5.03e-05	0.00071	CcSEcCtD
Trabectedin—Shock—Docetaxel—pancreatic cancer	5.01e-05	0.000708	CcSEcCtD
Trabectedin—Nervous system disorder—Docetaxel—pancreatic cancer	5e-05	0.000706	CcSEcCtD
Trabectedin—Thrombocytopenia—Docetaxel—pancreatic cancer	4.99e-05	0.000704	CcSEcCtD
Trabectedin—Infestation NOS—Doxorubicin—pancreatic cancer	4.99e-05	0.000704	CcSEcCtD
Trabectedin—Infestation—Doxorubicin—pancreatic cancer	4.99e-05	0.000704	CcSEcCtD
Trabectedin—Skin disorder—Docetaxel—pancreatic cancer	4.95e-05	0.000699	CcSEcCtD
Trabectedin—Diarrhoea—Gemcitabine—pancreatic cancer	4.91e-05	0.000694	CcSEcCtD
Trabectedin—Dizziness—Irinotecan—pancreatic cancer	4.87e-05	0.000688	CcSEcCtD
Trabectedin—Haemoglobin—Epirubicin—pancreatic cancer	4.86e-05	0.000687	CcSEcCtD
Trabectedin—Stomatitis—Doxorubicin—pancreatic cancer	4.86e-05	0.000686	CcSEcCtD
Trabectedin—Jaundice—Doxorubicin—pancreatic cancer	4.86e-05	0.000686	CcSEcCtD
Trabectedin—Anorexia—Docetaxel—pancreatic cancer	4.86e-05	0.000686	CcSEcCtD
Trabectedin—Haemorrhage—Epirubicin—pancreatic cancer	4.84e-05	0.000683	CcSEcCtD
Trabectedin—Diarrhoea—Fluorouracil—pancreatic cancer	4.83e-05	0.000682	CcSEcCtD
Trabectedin—Oedema peripheral—Epirubicin—pancreatic cancer	4.77e-05	0.000673	CcSEcCtD
Trabectedin—Hypotension—Docetaxel—pancreatic cancer	4.76e-05	0.000672	CcSEcCtD
Trabectedin—Connective tissue disorder—Epirubicin—pancreatic cancer	4.75e-05	0.000671	CcSEcCtD
Trabectedin—Hepatobiliary disease—Doxorubicin—pancreatic cancer	4.72e-05	0.000666	CcSEcCtD
Trabectedin—Vomiting—Irinotecan—pancreatic cancer	4.69e-05	0.000662	CcSEcCtD
Trabectedin—Dizziness—Fluorouracil—pancreatic cancer	4.67e-05	0.000659	CcSEcCtD
Trabectedin—Agranulocytosis—Doxorubicin—pancreatic cancer	4.65e-05	0.000657	CcSEcCtD
Trabectedin—Rash—Irinotecan—pancreatic cancer	4.65e-05	0.000656	CcSEcCtD
Trabectedin—Dermatitis—Irinotecan—pancreatic cancer	4.64e-05	0.000656	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	4.64e-05	0.000656	CcSEcCtD
Trabectedin—Headache—Irinotecan—pancreatic cancer	4.62e-05	0.000652	CcSEcCtD
Trabectedin—Insomnia—Docetaxel—pancreatic cancer	4.61e-05	0.000651	CcSEcCtD
Trabectedin—Paraesthesia—Docetaxel—pancreatic cancer	4.58e-05	0.000646	CcSEcCtD
Trabectedin—Vomiting—Gemcitabine—pancreatic cancer	4.57e-05	0.000645	CcSEcCtD
Trabectedin—Dyspnoea—Docetaxel—pancreatic cancer	4.54e-05	0.000641	CcSEcCtD
Trabectedin—Rash—Gemcitabine—pancreatic cancer	4.53e-05	0.000639	CcSEcCtD
Trabectedin—Dermatitis—Gemcitabine—pancreatic cancer	4.52e-05	0.000639	CcSEcCtD
Trabectedin—Haemoglobin—Doxorubicin—pancreatic cancer	4.5e-05	0.000635	CcSEcCtD
Trabectedin—Headache—Gemcitabine—pancreatic cancer	4.5e-05	0.000635	CcSEcCtD
Trabectedin—Flushing—Epirubicin—pancreatic cancer	4.49e-05	0.000634	CcSEcCtD
Trabectedin—Vomiting—Fluorouracil—pancreatic cancer	4.49e-05	0.000634	CcSEcCtD
Trabectedin—Dyspepsia—Docetaxel—pancreatic cancer	4.49e-05	0.000633	CcSEcCtD
Trabectedin—Haemorrhage—Doxorubicin—pancreatic cancer	4.48e-05	0.000632	CcSEcCtD
Trabectedin—Rash—Fluorouracil—pancreatic cancer	4.45e-05	0.000629	CcSEcCtD
Trabectedin—Dermatitis—Fluorouracil—pancreatic cancer	4.45e-05	0.000628	CcSEcCtD
Trabectedin—Decreased appetite—Docetaxel—pancreatic cancer	4.43e-05	0.000625	CcSEcCtD
Trabectedin—Headache—Fluorouracil—pancreatic cancer	4.42e-05	0.000624	CcSEcCtD
Trabectedin—Oedema peripheral—Doxorubicin—pancreatic cancer	4.41e-05	0.000623	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	4.4e-05	0.000621	CcSEcCtD
Trabectedin—Connective tissue disorder—Doxorubicin—pancreatic cancer	4.4e-05	0.000621	CcSEcCtD
Trabectedin—Fatigue—Docetaxel—pancreatic cancer	4.39e-05	0.00062	CcSEcCtD
Trabectedin—Angiopathy—Epirubicin—pancreatic cancer	4.39e-05	0.00062	CcSEcCtD
Trabectedin—Nausea—Irinotecan—pancreatic cancer	4.38e-05	0.000618	CcSEcCtD
Trabectedin—Mediastinal disorder—Epirubicin—pancreatic cancer	4.36e-05	0.000616	CcSEcCtD
Trabectedin—Constipation—Docetaxel—pancreatic cancer	4.36e-05	0.000615	CcSEcCtD
Trabectedin—Alopecia—Epirubicin—pancreatic cancer	4.28e-05	0.000604	CcSEcCtD
Trabectedin—Nausea—Gemcitabine—pancreatic cancer	4.27e-05	0.000602	CcSEcCtD
Trabectedin—Mental disorder—Epirubicin—pancreatic cancer	4.24e-05	0.000598	CcSEcCtD
Trabectedin—Malnutrition—Epirubicin—pancreatic cancer	4.21e-05	0.000595	CcSEcCtD
Trabectedin—Nausea—Fluorouracil—pancreatic cancer	4.19e-05	0.000592	CcSEcCtD
Trabectedin—Gastrointestinal pain—Docetaxel—pancreatic cancer	4.17e-05	0.000588	CcSEcCtD
Trabectedin—Flushing—Doxorubicin—pancreatic cancer	4.15e-05	0.000587	CcSEcCtD
Trabectedin—Dysgeusia—Epirubicin—pancreatic cancer	4.12e-05	0.000582	CcSEcCtD
Trabectedin—Back pain—Epirubicin—pancreatic cancer	4.07e-05	0.000575	CcSEcCtD
Trabectedin—Angiopathy—Doxorubicin—pancreatic cancer	4.06e-05	0.000573	CcSEcCtD
Trabectedin—Mediastinal disorder—Doxorubicin—pancreatic cancer	4.03e-05	0.00057	CcSEcCtD
Trabectedin—Abdominal pain—Docetaxel—pancreatic cancer	4.03e-05	0.000569	CcSEcCtD
Trabectedin—Body temperature increased—Docetaxel—pancreatic cancer	4.03e-05	0.000569	CcSEcCtD
Trabectedin—Alopecia—Doxorubicin—pancreatic cancer	3.96e-05	0.000559	CcSEcCtD
Trabectedin—Mental disorder—Doxorubicin—pancreatic cancer	3.92e-05	0.000554	CcSEcCtD
Trabectedin—Malnutrition—Doxorubicin—pancreatic cancer	3.9e-05	0.00055	CcSEcCtD
Trabectedin—Anaemia—Epirubicin—pancreatic cancer	3.89e-05	0.00055	CcSEcCtD
Trabectedin—Dysgeusia—Doxorubicin—pancreatic cancer	3.82e-05	0.000539	CcSEcCtD
Trabectedin—Syncope—Epirubicin—pancreatic cancer	3.78e-05	0.000533	CcSEcCtD
Trabectedin—Leukopenia—Epirubicin—pancreatic cancer	3.77e-05	0.000532	CcSEcCtD
Trabectedin—Back pain—Doxorubicin—pancreatic cancer	3.77e-05	0.000532	CcSEcCtD
Trabectedin—Hypersensitivity—Docetaxel—pancreatic cancer	3.75e-05	0.00053	CcSEcCtD
Trabectedin—Loss of consciousness—Epirubicin—pancreatic cancer	3.7e-05	0.000523	CcSEcCtD
Trabectedin—Cough—Epirubicin—pancreatic cancer	3.68e-05	0.000519	CcSEcCtD
Trabectedin—Asthenia—Docetaxel—pancreatic cancer	3.66e-05	0.000516	CcSEcCtD
Trabectedin—Anaemia—Doxorubicin—pancreatic cancer	3.6e-05	0.000509	CcSEcCtD
Trabectedin—Myalgia—Epirubicin—pancreatic cancer	3.59e-05	0.000506	CcSEcCtD
Trabectedin—Arthralgia—Epirubicin—pancreatic cancer	3.59e-05	0.000506	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	3.56e-05	0.000503	CcSEcCtD
Trabectedin—Syncope—Doxorubicin—pancreatic cancer	3.49e-05	0.000493	CcSEcCtD
Trabectedin—Leukopenia—Doxorubicin—pancreatic cancer	3.49e-05	0.000492	CcSEcCtD
Trabectedin—Diarrhoea—Docetaxel—pancreatic cancer	3.49e-05	0.000492	CcSEcCtD
Trabectedin—Oedema—Epirubicin—pancreatic cancer	3.44e-05	0.000485	CcSEcCtD
Trabectedin—Loss of consciousness—Doxorubicin—pancreatic cancer	3.43e-05	0.000484	CcSEcCtD
Trabectedin—Infection—Epirubicin—pancreatic cancer	3.41e-05	0.000482	CcSEcCtD
Trabectedin—Cough—Doxorubicin—pancreatic cancer	3.4e-05	0.00048	CcSEcCtD
Trabectedin—Shock—Epirubicin—pancreatic cancer	3.38e-05	0.000477	CcSEcCtD
Trabectedin—Nervous system disorder—Epirubicin—pancreatic cancer	3.37e-05	0.000476	CcSEcCtD
Trabectedin—Dizziness—Docetaxel—pancreatic cancer	3.37e-05	0.000476	CcSEcCtD
Trabectedin—Thrombocytopenia—Epirubicin—pancreatic cancer	3.37e-05	0.000475	CcSEcCtD
Trabectedin—Skin disorder—Epirubicin—pancreatic cancer	3.34e-05	0.000471	CcSEcCtD
Trabectedin—Myalgia—Doxorubicin—pancreatic cancer	3.32e-05	0.000468	CcSEcCtD
Trabectedin—Arthralgia—Doxorubicin—pancreatic cancer	3.32e-05	0.000468	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	3.29e-05	0.000465	CcSEcCtD
Trabectedin—Anorexia—Epirubicin—pancreatic cancer	3.28e-05	0.000463	CcSEcCtD
Trabectedin—Vomiting—Docetaxel—pancreatic cancer	3.24e-05	0.000457	CcSEcCtD
Trabectedin—Rash—Docetaxel—pancreatic cancer	3.21e-05	0.000454	CcSEcCtD
Trabectedin—Hypotension—Epirubicin—pancreatic cancer	3.21e-05	0.000453	CcSEcCtD
Trabectedin—Dermatitis—Docetaxel—pancreatic cancer	3.21e-05	0.000453	CcSEcCtD
Trabectedin—Headache—Docetaxel—pancreatic cancer	3.19e-05	0.000451	CcSEcCtD
Trabectedin—Oedema—Doxorubicin—pancreatic cancer	3.18e-05	0.000449	CcSEcCtD
Trabectedin—Infection—Doxorubicin—pancreatic cancer	3.16e-05	0.000446	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	3.13e-05	0.000442	CcSEcCtD
Trabectedin—Shock—Doxorubicin—pancreatic cancer	3.13e-05	0.000442	CcSEcCtD
Trabectedin—Nervous system disorder—Doxorubicin—pancreatic cancer	3.12e-05	0.00044	CcSEcCtD
Trabectedin—Thrombocytopenia—Doxorubicin—pancreatic cancer	3.11e-05	0.00044	CcSEcCtD
Trabectedin—Insomnia—Epirubicin—pancreatic cancer	3.11e-05	0.000439	CcSEcCtD
Trabectedin—Skin disorder—Doxorubicin—pancreatic cancer	3.09e-05	0.000436	CcSEcCtD
Trabectedin—Paraesthesia—Epirubicin—pancreatic cancer	3.09e-05	0.000436	CcSEcCtD
Trabectedin—Dyspnoea—Epirubicin—pancreatic cancer	3.06e-05	0.000433	CcSEcCtD
Trabectedin—Anorexia—Doxorubicin—pancreatic cancer	3.03e-05	0.000428	CcSEcCtD
Trabectedin—Nausea—Docetaxel—pancreatic cancer	3.03e-05	0.000427	CcSEcCtD
Trabectedin—Dyspepsia—Epirubicin—pancreatic cancer	3.03e-05	0.000427	CcSEcCtD
Trabectedin—Decreased appetite—Epirubicin—pancreatic cancer	2.99e-05	0.000422	CcSEcCtD
Trabectedin—Hypotension—Doxorubicin—pancreatic cancer	2.97e-05	0.00042	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	2.97e-05	0.000419	CcSEcCtD
Trabectedin—Fatigue—Epirubicin—pancreatic cancer	2.96e-05	0.000418	CcSEcCtD
Trabectedin—Constipation—Epirubicin—pancreatic cancer	2.94e-05	0.000415	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	2.9e-05	0.000409	CcSEcCtD
Trabectedin—Insomnia—Doxorubicin—pancreatic cancer	2.88e-05	0.000406	CcSEcCtD
Trabectedin—Paraesthesia—Doxorubicin—pancreatic cancer	2.86e-05	0.000403	CcSEcCtD
Trabectedin—Dyspnoea—Doxorubicin—pancreatic cancer	2.84e-05	0.0004	CcSEcCtD
Trabectedin—Gastrointestinal pain—Epirubicin—pancreatic cancer	2.81e-05	0.000397	CcSEcCtD
Trabectedin—Dyspepsia—Doxorubicin—pancreatic cancer	2.8e-05	0.000395	CcSEcCtD
Trabectedin—Decreased appetite—Doxorubicin—pancreatic cancer	2.76e-05	0.00039	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	2.75e-05	0.000388	CcSEcCtD
Trabectedin—Fatigue—Doxorubicin—pancreatic cancer	2.74e-05	0.000387	CcSEcCtD
Trabectedin—Constipation—Doxorubicin—pancreatic cancer	2.72e-05	0.000384	CcSEcCtD
Trabectedin—Body temperature increased—Epirubicin—pancreatic cancer	2.72e-05	0.000384	CcSEcCtD
Trabectedin—Abdominal pain—Epirubicin—pancreatic cancer	2.72e-05	0.000384	CcSEcCtD
Trabectedin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	2.6e-05	0.000367	CcSEcCtD
Trabectedin—Hypersensitivity—Epirubicin—pancreatic cancer	2.53e-05	0.000358	CcSEcCtD
Trabectedin—Abdominal pain—Doxorubicin—pancreatic cancer	2.51e-05	0.000355	CcSEcCtD
Trabectedin—Body temperature increased—Doxorubicin—pancreatic cancer	2.51e-05	0.000355	CcSEcCtD
Trabectedin—Asthenia—Epirubicin—pancreatic cancer	2.47e-05	0.000348	CcSEcCtD
Trabectedin—Diarrhoea—Epirubicin—pancreatic cancer	2.35e-05	0.000332	CcSEcCtD
Trabectedin—Hypersensitivity—Doxorubicin—pancreatic cancer	2.34e-05	0.000331	CcSEcCtD
Trabectedin—Asthenia—Doxorubicin—pancreatic cancer	2.28e-05	0.000322	CcSEcCtD
Trabectedin—Dizziness—Epirubicin—pancreatic cancer	2.27e-05	0.000321	CcSEcCtD
Trabectedin—Vomiting—Epirubicin—pancreatic cancer	2.19e-05	0.000309	CcSEcCtD
Trabectedin—Diarrhoea—Doxorubicin—pancreatic cancer	2.18e-05	0.000307	CcSEcCtD
Trabectedin—Rash—Epirubicin—pancreatic cancer	2.17e-05	0.000306	CcSEcCtD
Trabectedin—Dermatitis—Epirubicin—pancreatic cancer	2.17e-05	0.000306	CcSEcCtD
Trabectedin—Headache—Epirubicin—pancreatic cancer	2.15e-05	0.000304	CcSEcCtD
Trabectedin—Dizziness—Doxorubicin—pancreatic cancer	2.1e-05	0.000297	CcSEcCtD
Trabectedin—Nausea—Epirubicin—pancreatic cancer	2.04e-05	0.000288	CcSEcCtD
Trabectedin—Vomiting—Doxorubicin—pancreatic cancer	2.02e-05	0.000286	CcSEcCtD
Trabectedin—Rash—Doxorubicin—pancreatic cancer	2.01e-05	0.000283	CcSEcCtD
Trabectedin—Dermatitis—Doxorubicin—pancreatic cancer	2e-05	0.000283	CcSEcCtD
Trabectedin—Headache—Doxorubicin—pancreatic cancer	1.99e-05	0.000281	CcSEcCtD
Trabectedin—Nausea—Doxorubicin—pancreatic cancer	1.89e-05	0.000267	CcSEcCtD
Trabectedin—SRC—Innate Immune System—PIK3CD—pancreatic cancer	7.53e-06	0.000284	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—JAG2—pancreatic cancer	7.48e-06	0.000283	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—AKT1—pancreatic cancer	7.45e-06	0.000281	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ARG2—pancreatic cancer	7.42e-06	0.00028	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MEN1—pancreatic cancer	7.37e-06	0.000278	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—GLP1R—pancreatic cancer	7.36e-06	0.000278	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ARG2—pancreatic cancer	7.35e-06	0.000278	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—EGFR—pancreatic cancer	7.31e-06	0.000276	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—PIK3CB—pancreatic cancer	7.29e-06	0.000275	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—DPYD—pancreatic cancer	7.25e-06	0.000274	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—PIK3CD—pancreatic cancer	7.23e-06	0.000273	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—CD44—pancreatic cancer	7.12e-06	0.000269	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—TYMP—pancreatic cancer	7.05e-06	0.000266	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	7.04e-06	0.000266	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—SHH—pancreatic cancer	7.03e-06	0.000266	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—PIK3CA—pancreatic cancer	7.01e-06	0.000265	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NOTCH4—pancreatic cancer	6.99e-06	0.000264	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.98e-06	0.000264	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IAPP—pancreatic cancer	6.94e-06	0.000262	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.91e-06	0.000261	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—KRAS—pancreatic cancer	6.91e-06	0.000261	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—SLC2A2—pancreatic cancer	6.88e-06	0.00026	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—GCG—pancreatic cancer	6.83e-06	0.000258	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PTHLH—pancreatic cancer	6.66e-06	0.000252	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PTCH1—pancreatic cancer	6.66e-06	0.000252	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—CTNNB1—pancreatic cancer	6.59e-06	0.000249	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—PIK3CB—pancreatic cancer	6.56e-06	0.000248	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—HRAS—pancreatic cancer	6.49e-06	0.000245	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—TYMP—pancreatic cancer	6.48e-06	0.000245	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—MMP9—pancreatic cancer	6.46e-06	0.000244	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—TYMP—pancreatic cancer	6.43e-06	0.000243	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—STK11—pancreatic cancer	6.42e-06	0.000243	CbGpPWpGaD
Trabectedin—SRC—Disease—SMAD4—pancreatic cancer	6.39e-06	0.000241	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—PIK3CB—pancreatic cancer	6.3e-06	0.000238	CbGpPWpGaD
Trabectedin—SRC—Disease—HES1—pancreatic cancer	6.24e-06	0.000236	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—SST—pancreatic cancer	6.1e-06	0.00023	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.03e-06	0.000228	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—JAG1—pancreatic cancer	5.96e-06	0.000225	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NOTCH3—pancreatic cancer	5.94e-06	0.000224	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—HRAS—pancreatic cancer	5.87e-06	0.000222	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CTNNB1—pancreatic cancer	5.82e-06	0.00022	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	5.82e-06	0.00022	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—VEGFA—pancreatic cancer	5.8e-06	0.000219	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—STAT3—pancreatic cancer	5.74e-06	0.000217	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—AKT1—pancreatic cancer	5.73e-06	0.000216	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—NRAS—pancreatic cancer	5.73e-06	0.000216	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—VEGFA—pancreatic cancer	5.69e-06	0.000215	CbGpPWpGaD
Trabectedin—SRC—Immune System—BCL2L1—pancreatic cancer	5.68e-06	0.000215	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GLP1R—pancreatic cancer	5.68e-06	0.000215	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—PTEN—pancreatic cancer	5.67e-06	0.000214	CbGpPWpGaD
Trabectedin—SRC—Immune System—TSC2—pancreatic cancer	5.65e-06	0.000213	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CNR1—pancreatic cancer	5.63e-06	0.000213	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—NRAS—pancreatic cancer	5.62e-06	0.000212	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PRSS1—pancreatic cancer	5.59e-06	0.000211	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—DPYD—pancreatic cancer	5.59e-06	0.000211	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—TYMS—pancreatic cancer	5.52e-06	0.000209	CbGpPWpGaD
Trabectedin—SRC—Disease—TERT—pancreatic cancer	5.47e-06	0.000207	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—PTEN—pancreatic cancer	5.45e-06	0.000206	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—GCG—pancreatic cancer	5.43e-06	0.000205	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CD44—pancreatic cancer	5.32e-06	0.000201	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—TGFB1—pancreatic cancer	5.32e-06	0.000201	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	5.3e-06	0.0002	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	5.3e-06	0.0002	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	5.25e-06	0.000198	CbGpPWpGaD
Trabectedin—SRC—Disease—HIF1A—pancreatic cancer	5.23e-06	0.000198	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GLP1R—pancreatic cancer	5.23e-06	0.000197	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—TGFB1—pancreatic cancer	5.22e-06	0.000197	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—EGFR—pancreatic cancer	5.22e-06	0.000197	CbGpPWpGaD
Trabectedin—SRC—Disease—TSC2—pancreatic cancer	5.21e-06	0.000197	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—AGTR1—pancreatic cancer	5.18e-06	0.000196	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GLP1R—pancreatic cancer	5.18e-06	0.000196	CbGpPWpGaD
Trabectedin—SRC—Immune System—NFKBIA—pancreatic cancer	5.15e-06	0.000195	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—DPYD—pancreatic cancer	5.14e-06	0.000194	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—STK11—pancreatic cancer	5.11e-06	0.000193	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—GCG—pancreatic cancer	5.1e-06	0.000193	CbGpPWpGaD
Trabectedin—SRC—Disease—APOE—pancreatic cancer	5.1e-06	0.000193	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—DPYD—pancreatic cancer	5.1e-06	0.000193	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.07e-06	0.000191	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—NRAS—pancreatic cancer	5.06e-06	0.000191	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—TNF—pancreatic cancer	4.97e-06	0.000188	CbGpPWpGaD
Trabectedin—SRC—Immune System—EGF—pancreatic cancer	4.93e-06	0.000186	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—KRAS—pancreatic cancer	4.93e-06	0.000186	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	4.88e-06	0.000184	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—NRAS—pancreatic cancer	4.86e-06	0.000184	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ARG2—pancreatic cancer	4.85e-06	0.000183	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	4.84e-06	0.000183	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—KRAS—pancreatic cancer	4.84e-06	0.000183	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—STK11—pancreatic cancer	4.8e-06	0.000181	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.79e-06	0.000181	CbGpPWpGaD
Trabectedin—SRC—Disease—NOTCH1—pancreatic cancer	4.71e-06	0.000178	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.62e-06	0.000175	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.61e-06	0.000174	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—EGFR—pancreatic cancer	4.61e-06	0.000174	CbGpPWpGaD
Trabectedin—SRC—Immune System—CDH1—pancreatic cancer	4.59e-06	0.000173	CbGpPWpGaD
Trabectedin—SRC—Disease—EGF—pancreatic cancer	4.55e-06	0.000172	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—APOE—pancreatic cancer	4.49e-06	0.00017	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—SMAD4—pancreatic cancer	4.47e-06	0.000169	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—PIK3CA—pancreatic cancer	4.44e-06	0.000168	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—EGFR—pancreatic cancer	4.43e-06	0.000167	CbGpPWpGaD
Trabectedin—SRC—Immune System—PIK3CD—pancreatic cancer	4.38e-06	0.000166	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HES1—pancreatic cancer	4.37e-06	0.000165	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—KRAS—pancreatic cancer	4.35e-06	0.000165	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—TP53—pancreatic cancer	4.3e-06	0.000162	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.25e-06	0.000161	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—TYMP—pancreatic cancer	4.24e-06	0.00016	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.21e-06	0.000159	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—HRAS—pancreatic cancer	4.19e-06	0.000158	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—KRAS—pancreatic cancer	4.18e-06	0.000158	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—TYMS—pancreatic cancer	4.13e-06	0.000156	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—HRAS—pancreatic cancer	4.11e-06	0.000155	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CD44—pancreatic cancer	4.11e-06	0.000155	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PIK3CG—pancreatic cancer	4.05e-06	0.000153	CbGpPWpGaD
Trabectedin—SRC—Disease—PIK3CD—pancreatic cancer	4.05e-06	0.000153	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.02e-06	0.000152	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—PIK3CA—pancreatic cancer	4e-06	0.000151	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.99e-06	0.000151	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GCG—pancreatic cancer	3.94e-06	0.000149	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PPARG—pancreatic cancer	3.91e-06	0.000148	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—PIK3CA—pancreatic cancer	3.84e-06	0.000145	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TERT—pancreatic cancer	3.83e-06	0.000145	CbGpPWpGaD
Trabectedin—SRC—Immune System—PIK3CB—pancreatic cancer	3.82e-06	0.000144	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CD44—pancreatic cancer	3.78e-06	0.000143	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CD44—pancreatic cancer	3.75e-06	0.000142	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—STK11—pancreatic cancer	3.7e-06	0.00014	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—HRAS—pancreatic cancer	3.7e-06	0.00014	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—AKT1—pancreatic cancer	3.7e-06	0.00014	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.67e-06	0.000139	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HIF1A—pancreatic cancer	3.66e-06	0.000138	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TSC2—pancreatic cancer	3.65e-06	0.000138	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.63e-06	0.000137	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—AKT1—pancreatic cancer	3.63e-06	0.000137	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GCG—pancreatic cancer	3.62e-06	0.000137	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GCG—pancreatic cancer	3.59e-06	0.000136	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—APOE—pancreatic cancer	3.57e-06	0.000135	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PIK3CD—pancreatic cancer	3.56e-06	0.000135	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—HRAS—pancreatic cancer	3.55e-06	0.000134	CbGpPWpGaD
Trabectedin—SRC—Disease—PIK3CB—pancreatic cancer	3.53e-06	0.000133	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—KDR—pancreatic cancer	3.5e-06	0.000132	CbGpPWpGaD
Trabectedin—SRC—Disease—PTGS2—pancreatic cancer	3.5e-06	0.000132	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.48e-06	0.000131	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GLP1R—pancreatic cancer	3.42e-06	0.000129	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—STK11—pancreatic cancer	3.41e-06	0.000129	CbGpPWpGaD
Trabectedin—SRC—Immune System—CTNNB1—pancreatic cancer	3.39e-06	0.000128	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—STK11—pancreatic cancer	3.38e-06	0.000128	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—DPYD—pancreatic cancer	3.36e-06	0.000127	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—APOE—pancreatic cancer	3.36e-06	0.000127	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NFKBIA—pancreatic cancer	3.33e-06	0.000126	CbGpPWpGaD
Trabectedin—SRC—Immune System—PTEN—pancreatic cancer	3.3e-06	0.000125	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NOTCH1—pancreatic cancer	3.3e-06	0.000125	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—AKT1—pancreatic cancer	3.27e-06	0.000123	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PIK3CG—pancreatic cancer	3.22e-06	0.000122	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	3.19e-06	0.000121	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EGF—pancreatic cancer	3.19e-06	0.00012	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—TYMS—pancreatic cancer	3.19e-06	0.00012	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.17e-06	0.00012	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—AKT1—pancreatic cancer	3.14e-06	0.000119	CbGpPWpGaD
Trabectedin—SRC—Disease—CTNNB1—pancreatic cancer	3.13e-06	0.000118	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PIK3CB—pancreatic cancer	3.11e-06	0.000117	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PTGS2—pancreatic cancer	3.08e-06	0.000116	CbGpPWpGaD
Trabectedin—SRC—Disease—PTEN—pancreatic cancer	3.05e-06	0.000115	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PIK3CG—pancreatic cancer	3.03e-06	0.000114	CbGpPWpGaD
Trabectedin—SRC—Immune System—STAT3—pancreatic cancer	2.95e-06	0.000112	CbGpPWpGaD
Trabectedin—SRC—Immune System—NRAS—pancreatic cancer	2.95e-06	0.000111	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—TYMS—pancreatic cancer	2.93e-06	0.000111	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PPARG—pancreatic cancer	2.92e-06	0.00011	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—TYMS—pancreatic cancer	2.9e-06	0.00011	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PIK3CD—pancreatic cancer	2.84e-06	0.000107	CbGpPWpGaD
Trabectedin—SRC—Disease—STAT3—pancreatic cancer	2.73e-06	0.000103	CbGpPWpGaD
Trabectedin—SRC—Disease—NRAS—pancreatic cancer	2.72e-06	0.000103	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PTEN—pancreatic cancer	2.68e-06	0.000101	CbGpPWpGaD
Trabectedin—SRC—Immune System—EGFR—pancreatic cancer	2.68e-06	0.000101	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PIK3CD—pancreatic cancer	2.66e-06	0.000101	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—APOE—pancreatic cancer	2.59e-06	9.79e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—KRAS—pancreatic cancer	2.54e-06	9.58e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—MYC—pancreatic cancer	2.53e-06	9.57e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—TGFB1—pancreatic cancer	2.53e-06	9.55e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—EGFR—pancreatic cancer	2.48e-06	9.36e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PIK3CB—pancreatic cancer	2.47e-06	9.34e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CD44—pancreatic cancer	2.47e-06	9.33e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.45e-06	9.26e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—APOE—pancreatic cancer	2.38e-06	9e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CXCL8—pancreatic cancer	2.37e-06	8.97e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GCG—pancreatic cancer	2.37e-06	8.95e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—APOE—pancreatic cancer	2.36e-06	8.92e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—KRAS—pancreatic cancer	2.34e-06	8.85e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	2.34e-06	8.83e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—PIK3CA—pancreatic cancer	2.33e-06	8.8e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PIK3CB—pancreatic cancer	2.32e-06	8.77e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PTGS2—pancreatic cancer	2.3e-06	8.69e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CASP3—pancreatic cancer	2.27e-06	8.59e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PPARG—pancreatic cancer	2.26e-06	8.53e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.24e-06	8.45e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—STK11—pancreatic cancer	2.23e-06	8.41e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CCND1—pancreatic cancer	2.21e-06	8.36e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CTNNB1—pancreatic cancer	2.19e-06	8.28e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—HRAS—pancreatic cancer	2.16e-06	8.14e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—PIK3CA—pancreatic cancer	2.15e-06	8.13e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	2.15e-06	8.12e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MMP9—pancreatic cancer	2.15e-06	8.12e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PTEN—pancreatic cancer	2.14e-06	8.07e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	2.13e-06	8.05e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PPARG—pancreatic cancer	2.08e-06	7.84e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PPARG—pancreatic cancer	2.06e-06	7.77e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	2.06e-06	7.77e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PTEN—pancreatic cancer	2.01e-06	7.58e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—HRAS—pancreatic cancer	1.99e-06	7.52e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—VEGFA—pancreatic cancer	1.93e-06	7.29e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.92e-06	7.24e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—STAT3—pancreatic cancer	1.91e-06	7.22e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NRAS—pancreatic cancer	1.91e-06	7.2e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—AKT1—pancreatic cancer	1.9e-06	7.19e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PIK3CA—pancreatic cancer	1.89e-06	7.16e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	1.89e-06	7.14e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	1.87e-06	7.08e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	1.79e-06	6.77e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PTGS2—pancreatic cancer	1.77e-06	6.71e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MYC—pancreatic cancer	1.77e-06	6.7e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TGFB1—pancreatic cancer	1.77e-06	6.69e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—AKT1—pancreatic cancer	1.76e-06	6.64e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EGFR—pancreatic cancer	1.74e-06	6.56e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	1.65e-06	6.23e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—KRAS—pancreatic cancer	1.64e-06	6.2e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	1.63e-06	6.17e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PTGS2—pancreatic cancer	1.63e-06	6.17e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PTGS2—pancreatic cancer	1.62e-06	6.11e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—APOE—pancreatic cancer	1.56e-06	5.89e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PTEN—pancreatic cancer	1.55e-06	5.85e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—AKT1—pancreatic cancer	1.55e-06	5.85e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PIK3CA—pancreatic cancer	1.51e-06	5.69e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TP53—pancreatic cancer	1.46e-06	5.51e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PTEN—pancreatic cancer	1.42e-06	5.38e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	1.42e-06	5.35e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PTEN—pancreatic cancer	1.41e-06	5.33e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.41e-06	5.31e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HRAS—pancreatic cancer	1.39e-06	5.27e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.36e-06	5.13e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.24e-06	4.67e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—AKT1—pancreatic cancer	1.23e-06	4.65e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—AKT1—pancreatic cancer	1.16e-06	4.37e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	1.09e-06	4.13e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.08e-06	4.07e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.07e-06	4.03e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1e-06	3.79e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	9.96e-07	3.76e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PTEN—pancreatic cancer	9.31e-07	3.52e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—AKT1—pancreatic cancer	8.92e-07	3.37e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—AKT1—pancreatic cancer	8.21e-07	3.1e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—AKT1—pancreatic cancer	8.13e-07	3.07e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	6.57e-07	2.48e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—AKT1—pancreatic cancer	5.36e-07	2.03e-05	CbGpPWpGaD
